Low/Intermediate PCa Video Chat, Jan 27, 2025

Low/Intermediate PCa Video Chat, Jan 27, 2025

It’s AnCan’s Annual Fundraiser time – just once a year is the only time we ask for donations. If you watch these videos and find them helpful, please step up ad donate – https://ancan.org/donate/

AnCan is grateful to the following sponsors for making this recording possible: Bayer, Foundation Medicine, Janssen, Myriad Genetics, Novartis, Telix & Blue Earth Diagnostics.

WELCOME all to our newly recorded Low/Intermediate Prostate Cancer Group. To receive notice when new recordings are posted, either follow us on this YouTube Channel or sign up to our Blog via https://ancan.org/contact-us/ – check New Blog box.

Join our other free and drop in groups:
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
AnCan’s Prostate Cancer Forum is back (https://ancan.org/forums). If you’d like to comment on anything you see in our Recordings or read in our Reminders, just sign up and go right ahead. You can also click on the Forum icon at the top right of the webpage.
All AnCan’s groups are free and drop-in … join us in person sometime!

Editor’s Pick: It is unwise to minimize needed prostate cancer treatment because earlier treatment generally leads to better outcomes. (bj)

Topics Discussed
Refuse a blind biopsy, timing of radiation therapy and ADT, rationality for Decipher Pro genomic test, PROMISE germline study, running out of biopsy samples, radiation oncologist vs genitourinary oncologist, evaluating different treatment options, treat prostate or whole pelvis, diet and nutrition during and after treatment, favorable vs unfavorable intermediate risk prostate cancer, active surveillance, brachytherapy, TULSA-PRO, SBRT, IMRT, Decipher Grid, focal treatment, is PSA still the gospel, decision anxiety, Cribriform discussion, RTIRE study, Men Speaking Freely.

Chat Log

AnCan  – rick
The PROMISE germline study https://www.prostatecancerpromise.org/?utm_campaign=ANCAN&utm_medium=link&utm_source=Webinar

John A
Survey deadline is this Thursday everyone.

AnCan  – rick
This link is now pinned to the  top, so reposting – tx Eric.   https://docs.google.com/forms/d/e/1FAIpQLSfw2B3rZTMWIPqTmzLYBl1CdN9qRJSpt0f72CoK6J00zllzWw/viewform

AnCan  – rick
You can donate to AnCan here: https://ancan.org/donate/

AnCan  – rick
David and Michael… do we have your email addresses for Reminders.

AnCan  – rick
Watch out for the Recording of tonight’s session. You can sign up for a reminder when published via our blog https://ancan.org/blog/  or our YouTube Channel https://www.youtube.com/channel/UCOX221U27DhVDCe3Ozz2rDg

AnCan  – rick
Next AS Group – Feb 5, 8.00 pm Eastern in this same room. Weekly for the first 4 Wednesdays.

AnCan  – rick
Decipher GRID

AnCan  – rick
You’re not alone, Mark!!

AnCan  – rick
Cribriform discussion – 30 min webinar  https://www.urotoday.com/video-lectures/a-journal-club-for-patients-with-prostate-cancer/video/mediaitem/4452-unfavorable-histology-classification-aims-to-reduce-unnecessary-treatment-journal-club-jesse-mckenney-cornelia-ding.html

AnCan  – rick
Epstein’s new email for reread:  gdeliguori@imppllc.com

Stuart
Ming Zhou – Ming.zhou@mountsinai.org

AnCan  – rick
Men Speaking Freely https://ancan.org/speaking-freely/

Mark Perloe
Thanks Richard

Sandy
Thanks all. very helpful again tonight. Signing off

Joe M, Victoria BC
Gotta sign off — thanks all for a good meeting.